Winton Group LTD Embecta Corp. Transaction History

Winton Group LTD

$1.72 Billion
Q2 2025

A detailed history of Winton Group LTD transactions in Embecta Corp. stock. As of the latest transaction made, Winton Group LTD holds 110,635 shares of EMBC stock, worth $1.58 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

110,635

Previous 84,912 30.29%

Holding current value

$1.58 Million

Previous $1.08 Million 0.92%

% of portfolio

0.06%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$9.28 - $13.3 $238,709 - $342,115	25,723 Added 30.29%	110,635 $1.07 Million
Q1 2025 May 15, 2025	BUY	$12.28 - $20.93 $193,667 - $330,087	15,771 Added 22.81%	84,912 $1.08 Million
Q4 2024 Feb 12, 2025	SELL	$12.51 - $20.83 $61,999 - $103,233	-4,956 Reduced 6.69%	69,141 $1.44 Million
Q3 2024 Nov 12, 2024	SELL	$11.46 - $16.56 $121,086 - $174,972	-10,566 Reduced 12.48%	74,097 $1.04 Million
Q2 2024 Aug 09, 2024	BUY	$10.13 - $14.6 $162,191 - $233,760	16,011 Added 23.32%	84,663 $1.06 Million
Q1 2024 May 14, 2024	BUY	$12.35 - $19.33 $499,928 - $782,478	40,480 Added 143.69%	68,652 $911,000
Q4 2023 Feb 12, 2024	BUY	$12.87 - $19.09 $41,003 - $60,820	3,186 Added 12.75%	28,172 $533,000
Q3 2023 Nov 13, 2023	BUY	$15.0 - $22.17 $130,800 - $193,322	8,720 Added 53.61%	24,986 $376,000
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $73,677 - $104,683	-3,411 Reduced 17.33%	16,266 $351,000
Q1 2023 May 12, 2023	BUY	$23.07 - $32.77 $61,873 - $87,889	2,682 Added 15.78%	19,677 $553,000
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $25,264 - $35,444	999 Added 6.25%	16,995 $429,000
Q3 2022 Nov 10, 2022	SELL	$24.0 - $33.42 $100,920 - $140,531	-4,205 Reduced 20.82%	15,996 $461,000
Q2 2022 Aug 10, 2022	BUY	$24.78 - $33.36 $500,580 - $673,905	20,201 New	20,201 $511,000

Others Institutions Holding EMBC

# of Institutions

413

Shares Held

58.1M

Call Options Held

26.7K

Put Options Held

74K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $828M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account